Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Haleos Labs's share price for the quarter that ended in Mar. 2026 was ₹1194.1. Haleos Labs's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 3 Mil. Therefore, Haleos Labs's market cap for the quarter that ended in Mar. 2026 was ₹3,610 Mil.
Haleos Labs's quarterly market cap
increased
from Sep. 2025 (₹3,409 Mil) to Dec. 2025 (₹4,002 Mil) but then
declined
from Dec. 2025 (₹4,002 Mil) to Mar. 2026 (₹3,610 Mil).
Haleos Labs's annual market cap
increased
from Mar. 2024 (₹2,044 Mil) to Mar. 2025 (₹3,259 Mil) and
increased
from Mar. 2025 (₹3,259 Mil) to Mar. 2026 (₹3,610 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Haleos Labs's Enterprise Value for Today is ₹6,221 Mil.
Haleos Labs (NSE:HALEOSLABS) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Haleos Labs Market Cap Related Terms
Haleos Labs Market Cap Historical Data
* Premium members only.
The historical data trend for Haleos Labs's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:HALEOSLABS vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, Haleos Labs's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haleos Labs Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Haleos Labs's Market Cap distribution charts can be found below:
* The bar in red indicates where Haleos Labs's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Haleos Labs's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haleos Labs (NSE:HALEOSLABS) has a Market Cap of ₹4,979 Mil as of Jul. 12, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Haleos Labs and its competitors. According to the industry distribution chart, Haleos Labs ranks #894 out of 1423 companies in the Biotechnology industry, placing it in the top 62.8%.
Is Haleos Labs' Market Cap too high?
Haleos Labs' current Market Cap is ₹4,979 Mil. Based on the distribution chart, Haleos Labs ranks #894 out of 1423 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Haleos Labs has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Haleos Labs' Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Haleos Labs ranks #894 out of 1423 companies for Market Cap. This places Haleos Labs in the lower half of its industry. The industry median Market Cap is 121.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 121.30, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Haleos Labs and its competitors. For the Biotechnology industry, the median Market Cap is 121.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Haleos Labs's current Market Cap is ₹4,979 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haleos Labs stock overvalued right now?
Based on GuruFocus' analysis, Haleos Labs (NSE:HALEOSLABS) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹1,124.05, compared to a current price of ₹1,596.60 — trading 42% above its estimated fair value. The current Market Cap is ₹4,979 Mil. Haleos Labs' overall GF Score™ is 76/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Haleos Labs (NSE:HALEOSLABS), the current Market Cap is ₹4,979 Mil as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Haleos Labs (NSE:HALEOSLABS) Overvalued in 2026?
Based on GuruFocus' analysis, Haleos Labs stock appears to be overvalued.
The current stock price of ₹1,596.60 is trading 42% above its estimated GF Value™ of ₹1,124.05.
GuruFocus considers Haleos Labs to be Significantly Overvalued.
Key valuation signals for NSE:HALEOSLABS:
Market Cap: ₹4,979 Mil
GF Value™: ₹1,124.05 vs. price of ₹1,596.60 (42% above fair value)
No single metric tells the full story. See the NSE:HALEOSLABS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Haleos Labs Ltd is engaged in the Business of manufacturing Active Pharmaceutical Ingredients (APIs) and its intermediates and sells its products in India as well as exports. The group sells its products in India and also exports it to other countries. Some of its API products are used in therapy as an Antiulcer, Antifungal, Anti Obesity, Anesthesia, and others. The company has manufacturing facilities at Kazipally and Jeedimetla and its Research and Development center at Sanatnagar in Hyderabad.
76GF Score
Get the complete analysis for NSE:HALEOSLABS
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:HALEOSLABS has been successfully added to your 
